382 (Quetiapine Fumarate Extended-Release 200 mg)

Pill with imprint 382 is Yellow, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 200 mg. It is supplied by ScieGen Pharmaceuticals, Inc.

Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 382

Quetiapine Fumarate Extended-Release

Imprint: 382
Strength: 200 mg
Color: Yellow
Size: 17.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Atypical antipsychotics
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: ScieGen Pharmaceuticals, Inc.
National Drug Code (NDC): 50228-0382
Inactive Ingredients: lactose monohydrate, microcrystalline cellulose, trisodium citrate dihydrate, magnesium stearate, polyethylene glycol 400, titanium dioxide, ferric oxide yellow
Note: Inactive ingredients may vary.